ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

HCFA Disregards Pleas From Centers, ACCC, Sen. Dole, NCAB, AACI; Final DRG Regulations Made Even Tougher

January 13, 1984

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

In Brief: Subcommittee Okays $980 Million for NCI In 1983, House Passes Waxman Bill, With Centers Line Item

October 8, 1982

Biomira Ends Agreement On Lymphoma Vaccine.

May 4, 2001

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012